Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
about
Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairmentOutcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitusOutcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients.The clinical utility of C-peptide measurement in the care of patients with diabetesUrea impairs β cell glycolysis and insulin secretion in chronic kidney disease.Transplant options for patients with type 2 diabetes and chronic kidney disease.Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.Challenges in pancreas transplantation.C-peptide and combined kidney-pancreas transplantation.C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry.Simultaneous pancreas kidney transplants in diabetic patients with end-stage renal disease: the 20-yr experience.[C-peptide residual secretion makes difference on type 1 diabetes management?].Curing diabetes with transplantation?Pancreas Transplantation of Non-Traditional Recipients
P2860
Q34407868-BE7712DD-4EAB-4E5D-A15E-16D4C25757C3Q34692276-1C2B2C2A-BF5E-4F8F-813E-48DBDB0F99BDQ34927182-2DCDF734-A8D6-4549-BDFC-475FF7CD4319Q37108880-CAEFB972-BCF4-4FCF-985D-203DB5BF9D8EQ37217519-93069077-3088-4FEF-BA8F-499DF70FD5EFQ38230451-82512D8E-9BE3-4B16-8AA6-3A89DC73DE88Q38356851-C50D6409-04FE-4159-A6BC-157D43F9EFFFQ38860630-68384767-6ED4-434C-970C-5759977819B4Q40324843-1F0B69DB-68A9-4F6E-B1F5-839823754AADQ40976863-76840CA4-EFC0-48FB-9196-326C85495B1DQ44696384-1AF865D0-7D2C-4E65-A60E-188F4671BB9BQ46625419-89DC5991-7882-4053-BE34-D807694271A5Q48455709-B730C38A-9266-4AF6-B307-9E5007B7D44CQ57457162-8314E33C-80F7-49D1-B37D-B742F334D11B
P2860
Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Serum C-peptide concentrations ...... -stage renal disease patients.
@en
Serum C-peptide concentrations ...... -stage renal disease patients.
@nl
type
label
Serum C-peptide concentrations ...... -stage renal disease patients.
@en
Serum C-peptide concentrations ...... -stage renal disease patients.
@nl
prefLabel
Serum C-peptide concentrations ...... -stage renal disease patients.
@en
Serum C-peptide concentrations ...... -stage renal disease patients.
@nl
P2093
P1433
P1476
Serum C-peptide concentrations ...... -stage renal disease patients.
@en
P2093
Constantiner M
Iyengar SK
Schelling JR
P304
P356
10.1046/J.1523-1755.2000.00335.X
P407
P577
2000-10-01T00:00:00Z
P5875
P6179
1041634571